Lotus Pharmaceuticals (LTUS)
0.005
0.00 (0.00%)
USD |
OTCM |
Apr 29, 16:00
Lotus Pharmaceuticals Enterprise Value: 0.2483M for April 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 29, 2024 | 0.2483M |
April 26, 2024 | 0.2483M |
April 25, 2024 | 0.2483M |
April 24, 2024 | 0.2483M |
April 23, 2024 | 0.2483M |
April 22, 2024 | 0.3039M |
April 19, 2024 | 0.3039M |
April 18, 2024 | 0.3039M |
April 17, 2024 | 0.3039M |
April 16, 2024 | 0.3039M |
April 15, 2024 | 0.3039M |
April 12, 2024 | 0.3039M |
April 11, 2024 | 0.3039M |
April 10, 2024 | 0.2483M |
April 09, 2024 | 0.2483M |
April 08, 2024 | 0.2483M |
April 05, 2024 | 0.2483M |
April 04, 2024 | 0.2483M |
April 03, 2024 | 0.2483M |
April 02, 2024 | 0.2483M |
April 01, 2024 | 0.2483M |
March 28, 2024 | 0.2483M |
March 27, 2024 | 0.2483M |
March 26, 2024 | 0.2483M |
March 25, 2024 | 0.2483M |
Date | Value |
---|---|
March 22, 2024 | 0.2205M |
March 21, 2024 | 0.2205M |
March 20, 2024 | 0.2205M |
March 19, 2024 | 0.2205M |
March 18, 2024 | 0.3178M |
March 15, 2024 | 0.3178M |
March 14, 2024 | 0.2622M |
March 13, 2024 | 0.2622M |
March 12, 2024 | 0.2622M |
March 11, 2024 | 0.2622M |
March 08, 2024 | 0.2817M |
March 07, 2024 | 0.3039M |
March 06, 2024 | 0.3039M |
March 05, 2024 | 0.2205M |
March 04, 2024 | 0.2205M |
March 01, 2024 | 0.2205M |
February 29, 2024 | 0.2205M |
February 28, 2024 | 0.2205M |
February 27, 2024 | 0.2205M |
February 26, 2024 | 0.2205M |
February 23, 2024 | 0.2622M |
February 22, 2024 | 0.2622M |
February 21, 2024 | 0.2622M |
February 20, 2024 | 0.2274M |
February 16, 2024 | 0.2274M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.2066M
Minimum
Jan 09 2024
0.3178M
Maximum
Mar 15 2024
0.2528M
Average
0.2622M
Median
Oct 02 2023
Enterprise Value Benchmarks
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.0044M |
Total Expenses (Quarterly) | 0.0044M |